Myxedema as a Reversible Cause of Ischemic Hepatitis: Severe Hashimoto’s Hypothyroidism Presenting with Profound Bradycardia, Hypotension and Marked Hypertransaminasemia
AJTES Vol 10, No. 2, July 2026
Llupi AH. et al. - Myxedema-Induced Ischemic Hepatitis.

Keywords

myxedema
hashimoto
bradycardia
hypertransaminasemia
severe hypotension

How to Cite

Llupi, A., Tafaj, I., Vasili, E., Toska, E., & Rroshaj, A. (2026). Myxedema as a Reversible Cause of Ischemic Hepatitis: Severe Hashimoto’s Hypothyroidism Presenting with Profound Bradycardia, Hypotension and Marked Hypertransaminasemia. Albanian Journal of Trauma and Emergency Surgery, 10(2), 2207-2211. https://doi.org/10.32391/ajtes.v10i2.554

Abstract

Background. Ischemic (hypoxic) hepatitis, the “shock liver” of the emergency setting, follows a fall in hepatic oxygen delivery, usually from cardiac, circulatory or respiratory failure, and produces a steep but short-lived rise in liver transaminases. Severe primary hypothyroidism is a classic yet easily forgotten cause of a reversible low-output circulation, and it can present first in the liver.

Case report. A 65-year-old man with no known thyroid disease presented to the emergency department with severe hypotension (60/40 mmHg) and bradycardia (45 beats/min) and marked hepatocellular injury (aspartate aminotransferase, AST, 1643 U/L; alanine aminotransferase, ALT, 819 U/L), with a minimally raised troponin and acute kidney injury. Lactate dehydrogenase was disproportionately elevated (LDH 1279 U/L; ALT-to-LDH ratio 0.7) and creatine kinase was markedly raised (CK 2946 U/L), while synthetic function was preserved. Viral serology was negative and the liver was structurally normal. As blood pressure recovered, the transaminases fell rapidly and the AST-to-ALT ratio reversed (from 2.0 to 0.3 by day 6). A coarse voice present for several weeks prompted thyroid testing, which showed TSH 80.371 mU/L, suppressed free hormones and anti-thyroid peroxidase antibodies of 848.77 IU/mL, establishing Hashimoto’s thyroiditis. Both the circulation and the liver recovered with fluids and levothyroxine.

Conclusion. In an obtunded, bradycardic, hypotensive patient with marked transaminase elevation and no viral, autoimmune or toxic explanation, severe hypothyroidism should be considered early. The ALT-to-LDH ratio and the reversal of the AST-to-ALT ratio help identify an ischemic mechanism, a markedly raised creatine kinase signals a coexisting hypothyroid myopathy contributing to the AST, and a single thyroid-stimulating hormone can redirect the entire differential.

https://doi.org/10.32391/ajtes.v10i2.554
Llupi AH. et al. - Myxedema-Induced Ischemic Hepatitis.

References

Henrion J. Hypoxic hepatitis. Liver Int. 2012;32(7):1039-1052. https://doi.org/10.1111/j.1478-3231.2011.02655.x

Ebert EC. Hypoxic liver injury. Mayo Clin Proc. 2006;81(9):1232-1236. https://doi.org/10.4065/81.9.1232

Henrion J, Schapira M, Luwaert R, Colin L, Delannoy A, Heller FR. Hypoxic hepatitis: clinical and hemodynamic study in 142 consecutive cases. Medicine (Baltimore). 2003;82(6):392-406. https://doi.org/10.1097/01.md.0000101573.54295.bd

Tapper EB, Sengupta N, Bonder A. The incidence and outcomes of ischemic hepatitis: a systematic review with meta-analysis. Am J Med. 2015;128(12):1314-1321. https://doi.org/10.1016/j.amjmed.2015.07.033

Cassidy WM, Reynolds TB. Serum lactic dehydrogenase in the differential diagnosis of acute hepatocellular injury. J Clin Gastroenterol. 1994;19(2):118-121. https://doi.org/10.1097/00004836-199409000-00008

Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med. 2001;344(7):501-509. https://doi.org/10.1056/NEJM200102153440707

Malik R, Hodgson H. The relationship between the thyroid gland and the liver. QJM. 2002;95(9):559-569. https://doi.org/10.1093/qjmed/95.9.559

Scott KR, Simmons Z, Boyer PJ. Hypothyroid myopathy with a strikingly elevated serum creatine kinase level. Muscle Nerve. 2002;26(1):141-144. https://doi.org/10.1002/mus.10128

Bano A, Chaker L, Plompen EPC, et al. Thyroid function and the risk of nonalcoholic fatty liver disease: the Rotterdam Study. J Clin Endocrinol Metab. 2016;101(8):3204-3211. https://doi.org/10.1210/jc.2016-1300

Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement. Thyroid. 2014;24(12):1670-1751. https://doi.org/10.1089/thy.2014.0028

Copyright (c) 2026 Arlinda Hysenj Llupi, Irgen Tafaj, Erald Vasili, Ergisa Toska, Artea Rroshaj